We are live on
!
Find out more
BC
Broadwood Capital Portfolio holdings
AUM
$1.91B
1-Year Est. Return
44.39%
This Fund
S&P 500
This Quarter
Est. Return
+3.32%
1 Year Est. Return
+44.39%
3 Year Est. Return
+110.36%
5 Year Est. Return
+52.4%
10 Year Est. Return
+1,142.23%
AUM
$1.17B
AUM Growth
+$48.6M
(+4.3%)
Cap. Flow
+$45M
Cap. Flow
% of AUM
3.84%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
STAAR Surgical
STAA
|
+$45.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Monster Beverage
MNST
|
+$707K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 41.68% |
| 2 | Healthcare | 31.91% |
| 3 | Industrials | 16.73% |
| 4 | Miscellaneous | 9.68% |
Similar funds
EWS
RMA
LWMT
FIB
SAM
HPC
R
CCIA
Broadwood Capital's Q4 2023 Portfolio in Review
As of Q4 2023, Broadwood Capital held 7 positions worth $1.17B, up 4.3% from $1.12B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Broadwood Capital deployed $45M of net new capital in Q4 2023, adding to 1 existing holding.
By sector, the portfolio is most concentrated in Consumer Staples at 42% of assets, up from 40% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Monster Beverage, an estimated $707K trimmed.
- Broadwood Capital added most to STAAR Surgical in Q4 2023, an estimated $45.8M increase.
- Broadwood Capital's biggest Q4 2023 reduction was Monster Beverage, cutting an estimated $707K.
- Broadwood Capital's ten largest holdings make up 100% of its $1.17B portfolio in Q4 2023.
- Broadwood Capital opened 0 new positions and closed 0 in Q4 2023.
- Broadwood Capital's portfolio value rose 4.3% quarter-over-quarter to $1.17B.
Based on Broadwood Capital's 13F filing for Q4 2023, filed 14 Feb 2024.